Literature DB >> 29315642

Human respiratory syncytial virus load normalized by cell quantification as predictor of acute respiratory tract infection.

Miriam Gómez-Novo1, José A Boga1, Marta E Álvarez-Argüelles1, Susana Rojo-Alba1, Ana Fernández1, María J Menéndez1, María de Oña1, Santiago Melón1.   

Abstract

Human respiratory syncytial virus (HRSV) is a common cause of respiratory infections. The main objective is to analyze the prediction ability of viral load of HRSV normalized by cell number in respiratory symptoms. A prospective, descriptive, and analytical study was performed. From 7307 respiratory samples processed between December 2014 to April 2016, 1019 HRSV-positive samples, were included in this study. Low respiratory tract infection was present in 729 patients (71.54%). Normalized HRSV load was calculated by quantification of HRSV genome and human β-globin gene and expressed as log10 copies/1000 cells. HRSV mean loads were 4.09 ± 2.08 and 4.82 ± 2.09 log10 copies/1000 cells in the 549 pharyngeal and 470 nasopharyngeal samples, respectively (P < 0.001). The viral mean load was 4.81 ± 1.98 log10 copies/1000 cells for patients under the age of 4-year-old (P < 0.001). The viral mean loads were 4.51 ± 2.04 cells in patients with low respiratory tract infection and 4.22 ± 2.28 log10 copies/1000 cells with upper respiratory tract infection or febrile syndrome (P < 0.05). A possible cut off value to predict LRTI evolution was tentatively established. Normalization of viral load by cell number in the samples is essential to ensure an optimal virological molecular diagnosis avoiding that the quality of samples affects the results. A high viral load can be a useful marker to predict disease progression.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cell counting; evolution; fusion protein; genetic variability; infection; pathogenesis; research and analysis methods; respiratory syncytial virus; respiratory tract; virus classification

Mesh:

Substances:

Year:  2018        PMID: 29315642     DOI: 10.1002/jmv.25020

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Seasonality, molecular epidemiology, and virulence of Respiratory Syncytial Virus (RSV): A perspective into the Brazilian Influenza Surveillance Program.

Authors:  Lucas A Vianna; Marilda M Siqueira; Lays P B Volpini; Iuri D Louro; Paola C Resende
Journal:  PLoS One       Date:  2021-05-18       Impact factor: 3.240

2.  Comparison of in-house SARS-CoV-2 genome extraction procedures. A need for COVID-19 pandemic.

Authors:  Gabriel Martín; Susana Rojo-Alba; Cristian Castelló-Abietar; Fátima Abreu-Salinas; Isabel Costales; Jose Antonio Boga; Santiago Melón; Marta Elena Álvarez-Argüelles
Journal:  J Virol Methods       Date:  2021-12-10       Impact factor: 2.014

3.  Effects of IFIH1 rs1990760 variants on systemic inflammation and outcome in critically ill COVID-19 patients in an observational translational study.

Authors:  Laura Amado-Rodríguez; Estefania Salgado Del Riego; Juan Gomez de Ona; Inés López Alonso; Helena Gil-Pena; Cecilia López-Martínez; Paula Martín-Vicente; Antonio Lopez-Vazquez; Adrian Gonzalez Lopez; Elias Cuesta-Llavona; Raquel Rodriguez-Garcia; Jose Antonio Boga; Marta Elena Alvarez-Arguelles; Juan Mayordomo-Colunga; Jose Ramon Vidal-Castineira; Irene Crespo; Margarita Fernandez; Loreto Criado; Victoria Salvadores; Francisco Jose Jimeno-Demuth; Lluis Blanch; Belen Prieto; Alejandra Fernandez-Fernandez; Carlos Lopez-Larrea; Eliecer Coto; Guillermo M Albaiceta
Journal:  Elife       Date:  2022-01-21       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.